Liquid Biopsy For Cancer Diagnostics Market to Reach $19.32 Billion By 2029, Growing at a CAGR of 15.7% - Insights From The Business Research Company’s Latest Report
The Liquid Biopsy For Cancer Diagnostics market has grown exponentially in recent years. From being worth $9.23 billion in 2024, it is projected to grow to $10.78 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 16.8%. Driving this growth are factors such as advancements in genomic research, increasing awareness of the benefits of liquid biopsy, a rise in cancer prevalence, growing demand for non-invasive cancer testing, and expansion of precision medicine initiatives.
The market is expected to see swift growth in the coming years, predicted to reach $19.32 billion in 2029 at a compound annual growth rate (CAGR) of 15.7%. This anticipated growth can be attributed to the integration of liquid biopsy in routine cancer diagnostics, rising interest in early cancer detection, expansion of cancer screening programs, growing focus on personalized medicine in oncology, and increased funding for liquid biopsy research. Significant trends anticipated in the forecast period include emergence of multi-omics liquid biopsy approaches, integration of artificial intelligence in liquid biopsy analysis, expansion of liquid biopsy applications beyond oncology and the development of blood-based biomarkers for cancer.
Get Your Free Sample of The Global Liquid Biopsy For Cancer Diagnostics Global Market Report 2024 Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12205&type=smp
What Are The Key Drivers For The Growth of the Liquid Biopsy for Cancer Diagnostics Market?
The rising prevalence of cancer has been identified as a significant driver for the liquid biopsy for cancer diagnostics market. Cancer refers to a category of diseases, with cells proliferating uncontrollably, crossing their normal boundaries, and either spreading to other organs or invading neighbouring body parts. The increasing incidence of cancer necessitates diagnostic procedures such as early cancer or tumor recurrence detection, risk assessment, and therapy monitoring, thereby driving the growth of the liquid biopsy for cancer diagnostics market.
What Are The Notable Market Segments?
The liquid biopsy for cancer diagnostics market covered in this report is segmented as:
1) By Type: Product, Services
2) By Sample: Blood, Urine, Saliva
3) By Cancer Type: Lung Cancer, Breast Cancer, Colon Cancer, Other Cancers
4) By End-User: Hospitals, Diagnostic Centers, Other End-Users
Order your report now for swift delivery:
https://www.thebusinessresearchcompany.com/report/liquid-biopsy-for-cancer-diagnostics-global-market-report
Which Major Companies Are Pioneering In The Liquid Biopsy for Cancer Diagnostics Market?
Major players operating in the liquid biopsy for cancer diagnostics market include F. Hoffman La Roche Ltd., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., The Menarini Group, Bio-Rad Laboratories Inc., QIAGEN Inc., Exact Sciences Corporation, Bio-Techne Corporation, ArcherDX Inc., Neogenomics Laboratories Inc., Guardant Health Inc., Myriad Genetics Inc., Foundation Medicine Inc., Amoy Diagnostics Co. Ltd., Biocartis Group NV, Biodesix Inc., MDx Health Inc., Sysmex Inostics Inc., Biocept Inc., Agena Bioscience Inc., Laboratory for Advanced Medicine (LAM) Inc., MiRXES Pte Ltd., Inivata Limited, Resolution Bioscience Inc., SAGA Diagnostics AB, NuProbe Inc., Personal Genome Diagnostics Inc., Pathway Genomics Corporation, and Angle PLC.
What Are The Emerging Trends in the Liquid Biopsy for Cancer Diagnostics Market?
Product innovation is a key trend gaining momentum in the liquid biopsy for cancer diagnostics market, with major companies focusing on creating innovative products to strengthen their market position.
Which Region Observes The Highest Growth in The Liquid Biopsy for Cancer Diagnostics Market?
North America was the largest region in the liquid biopsy for cancer diagnostics market in 2024. However, Asia-Pacific is expected to be the fastest-growing region during the forecast period. The liquid biopsy for cancer diagnostics market report covers Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
What Does The Liquid Biopsy For Cancer Diagnostics Global Market Report 2024 Report Offer?
The Liquid Biopsy For Cancer Diagnostics Global Market Report 2024 research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities. Liquid biopsy for cancer diagnostics is a less invasive method than traditional tissue biopsies, which include evaluating genetic material or biomarkers discovered in a patient's blood or other bodily fluids to find and monitor the presence of cancer.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12205
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead. Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Comments
Post a Comment